Sionna Therapeutics, Inc. Common Stock (SION)
Sionna Therapeutics, Inc. Common Stock (SION) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -22 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.5 | -13 | -10 | -18 | -12 | -16 | -18 | -15 | -17 | -22 | -72 | |
| 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.5 | 0.2 | 0.9 | |
| 0.6 | 0.6 | 1.0 | 1.0 | 1.1 | 2.1 | 2.8 | 3.3 | 3.8 | 6.6 | 17 | |
| 3.1 | -2.5 | -2.1 | -1.6 | 3.1 | -1.9 | -2.4 | 1.9 | -0.3 | -2.1 | -2.9 | |
| 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.2 | 0.0 | 0.3 | |
| 7.1 | -124 | -29 | 10 | 15 | -141 | -23 | 23 | 23 | 25 | 47 | |
| 0.0 | 181 | 0.0 | -1.0 | -1.4 | 202 | -0.3 | 2.0 | 1.7 | 1.9 | 5.2 | |
| -0.3 | 44 | -39 | -8.3 | 2.0 | 45 | -42 | 9.8 | 7.6 | 4.9 | -19 | |
| -7.6 | -13 | -10 | -18 | -12 | -16 | -18 | -15 | -17 | -22 | -72 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.